PuglisiSRossiniAPoliRDugheraFPiaATerzoloMet alEffects of SGLT2 inhibitors and GLP-1 receptor agonists on renin-angiotensin-aldosterone system
GLP-1 receptor agonists have exploded in popularity, with prescriptions increasing by 364 percent between 2019 and 2024
The gut microbiota and its metabolites have been proven to be closely related to the occurrence and development of central nervous system (CNS) diseases, especially in stroke patients (Han et al., 2023)
Immunotherapy Checkpoint inhibitors Pembrolizumab, nivolumab, ipilimumab, and relatlimab (in a fixed-dose formulation with nivolumab) are checkpoint inhibitors approved by the FDA
Reduces inflammation & oxidative stress Protects against fibrosis and scarring
However, certain antidepressants and semaglutide may share side effects, particularly nausea and changes in appetite